Polymerase chain reaction

Biocept Provides Update on COVID-19 Testing with More than 350,000 Samples Received to Date

Wednesday, April 14, 2021 - 1:05pm

(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that since the Company began offering SARS-CoV-2 testing services in June 2020, it has now received more than 350,000 samples for testing.

Key Points: 
  • (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that since the Company began offering SARS-CoV-2 testing services in June 2020, it has now received more than 350,000 samples for testing.
  • Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
  • The effects of such risks and uncertainties could cause actual results to differ materially from the forward-looking statements contained in this release.
  • We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law.

Eurofins Covid Testing Services Ltd (ECTS) Supports Reopening UK Travel by Making PCR Testing Affordable for All

Tuesday, April 13, 2021 - 4:45pm

b'Eurofins Covid Testing Services Ltd (ECTS) recognises the importance of testing in the fight against COVID-19.

Key Points: 
  • b'Eurofins Covid Testing Services Ltd (ECTS) recognises the importance of testing in the fight against COVID-19.
  • Only the PCR test can provide the accuracy, reliability and variant tracking required to ensure the continued safety of everyone in the UK and whilst travelling.\nECTS wants to support the airline, travel and tourism industries and facilitate travel for all by removing the barrier of expensive testing.
  • ECTS has therefore recently made significant investments in technology and automation to be able to drastically reduce the price of test-at-home PCR kits to just \xc2\xa344.90, providing the UK\xe2\x80\x99s lowest cost option for both Test-To-Depart and Test-To-Release.
  • With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins\xe2\x80\x99 companies offer a portfolio of over 200,000 analytical methods.\nEurofins Shares are listed on Euronext Paris Stock Exchange.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210413005843/en/\n'

FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.

Monday, April 12, 2021 - 12:00pm

View the full release here: https://www.businesswire.com/news/home/20210412005361/en/\nThe LUCIRA CHECK IT\xe2\x84\xa2 test kit provides PCR quality, COVID-19 results in 30 minutes or less in the comfort of home.

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210412005361/en/\nThe LUCIRA CHECK IT\xe2\x84\xa2 test kit provides PCR quality, COVID-19 results in 30 minutes or less in the comfort of home.
  • OTC clearance dramatically expands the availability of this highly accurate test.\nEach single-use test kit contains everything needed to conduct one COVID-19 test.
  • It can detect a positive result in as few as 11 minutes or confirm a negative result within 30 minutes.
  • Our goal was to produce an easy-to-use test that provides PCR quality accuracy in a portable, intuitive, anytime, anywhere format,\xe2\x80\x9d said Lucira CEO Erik Engelson.

GT Molecular launches highly sensitive PCR-based tests for UK, South African, and Brazilian/Japanese Variants of Concern

Wednesday, April 14, 2021 - 4:09pm

NationwideFee-for-servicetesting of wastewater samples for UK, South African, and Brazilian/Japanese Variants of SARS-CoV-2\n2.

Key Points: 
  • NationwideFee-for-servicetesting of wastewater samples for UK, South African, and Brazilian/Japanese Variants of SARS-CoV-2\n2.
  • "As mutations and variants gained traction, GT Molecular created new tools producing highly accurate, well-reported and timely variant data to our City, which has been shared throughout decision-makers in Florida.
  • GT Molecular\'s data has been validated by our state\'s lab as accurate and reliable.
  • says Dr. Lauren Stadler, Assistant Professor at Rice University.\nGT Molecular is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests.

FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test

Monday, April 12, 2021 - 1:00pm

"For population-wide testing programs, lab-based PCR is the best fitting technology, providing confidence in results, capacity to process thousands of samples a day, and consistent, reliable turnaround times.

Key Points: 
  • "For population-wide testing programs, lab-based PCR is the best fitting technology, providing confidence in results, capacity to process thousands of samples a day, and consistent, reliable turnaround times.
  • The Amplitude Solution can help support a systematic testing strategy by enabling labs to quickly scale their testing and begin processing high-volume samples, even with limited personnel.
  • "\nThe Amplitude Solution is a molecular diagnostic testing system that helps clinical labs expand testing capacity by combining Thermo Fisher\'s extraction and real-time PCR instruments with liquid handling products from Tecan Group.
  • 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.\nThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion.

Outlook on the Process Analytical Technology Global Market to 2025 - Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis

Friday, April 9, 2021 - 3:45pm

However, the high cost involved in the process of PAT (Process Analytical Technology) deployment and a dearth of skilled professionals are expected to hamper the market growth to a certain extent.

Key Points: 
  • However, the high cost involved in the process of PAT (Process Analytical Technology) deployment and a dearth of skilled professionals are expected to hamper the market growth to a certain extent.
  • Also, loopholes in the infrastructural sector in developing economies may create hindrances in the growth of the Global Process Analytical Technology Market.
  • The Global Process Analytical Technology Market is segmented further based on Technique, Measurements, End Users, Products & Services, and Geography.
  • By Technique, the market is classified into Spectroscopy, Chromatography, Particle Size Analysis, Capillary Electrophoresis, and Other techniques (such as calorimetry, thermal analysis, total organic carbon analysis, and FIA).

Oligonucleotide Synthesis Market worth $14.1 billion by 2026 - Exclusive Report by MarketsandMarkets™

Friday, April 9, 2021 - 3:30pm

Based on end users, the oligonucleotide synthesis market is categorized into hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & government institutes.

Key Points: 
  • Based on end users, the oligonucleotide synthesis market is categorized into hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & government institutes.
  • The PCR sub segment accounted for the largest share of the research application segment in the oligonucleotide synthesis market in 2020.
  • These PCR applications utilize sequence-specific primers, thus boosting the market for oligos (which are used as probes and primers) in the PCR market.
  • The Asia Pacific region is the fastest growing region of the oligonucleotide synthesis market in 2020.

Oligonucleotide Synthesis Market worth $14.1 billion by 2026 - Exclusive Report by MarketsandMarkets™

Friday, April 9, 2021 - 3:30pm

Based on end users, the oligonucleotide synthesis market is categorized into hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & government institutes.

Key Points: 
  • Based on end users, the oligonucleotide synthesis market is categorized into hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & government institutes.
  • The PCR sub segment accounted for the largest share of the research application segment in the oligonucleotide synthesis market in 2020.
  • These PCR applications utilize sequence-specific primers, thus boosting the market for oligos (which are used as probes and primers) in the PCR market.
  • The Asia Pacific region is the fastest growing region of the oligonucleotide synthesis market in 2020.

LUCIRA COVID-19 Test Kit Identifies Viral Variants

Friday, April 9, 2021 - 11:00am

Since we began this monitoring, our Lucira test kit has been reactive to more than 99.9% of available COVID-19 viral sequences, which are roughly 30,000 letters long.

Key Points: 
  • Since we began this monitoring, our Lucira test kit has been reactive to more than 99.9% of available COVID-19 viral sequences, which are roughly 30,000 letters long.
  • The LUCIRA COVID-19 All-In-One Test Kit Test Kit fits in the palm of a hand, extracts genetic material from the virus and amplifies it similar to PCR lab tests.
  • Each Lucira test kit contains everything needed to run one COVID-19 test.
  • The LUCIRA COVID-19 All-In-One Test Kit (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily

Thursday, April 8, 2021 - 3:00pm

To date, CertainT has ensured the authenticity of approximately 300 million pounds of North American Pima and Upland cotton and has been deployed to secure Egyptian and Australian cotton.

Key Points: 
  • To date, CertainT has ensured the authenticity of approximately 300 million pounds of North American Pima and Upland cotton and has been deployed to secure Egyptian and Australian cotton.
  • CertainT begins by authenticating the fiber content in cotton to confirm its origin.
  • The platform then employs a unique molecular identifier produced by the Companys LinearDNA platform to mark cotton fibers in bulk.
  • Applied DNA is commercializing LinearDNA, its proprietary, large-scale polymerase chain reaction (PCR)-based manufacturing platform that allows for the large-scale production of specific DNA sequences.